Literature DB >> 2159883

Activation of multiple signal transduction pathways by endothelin in cultured human vascular smooth muscle cells.

T J Resink1, T Scott-Burden, F R Bühler.   

Abstract

Cellular responses to the vasoconstrictor peptide, endothelin, have been investigated in quiescent cultured human vascular smooth muscle cells (hVSMC). Endothelin caused intracellular alkalinization and activation of the protein synthetic enzyme S6-kinase, but such responses were not associated with any mitogenic effects of endothelin on hVSMC. In myo-[3H]inositol-prelabelled hVSMC endothelin elicited a rapid increase in inositol bis- and tris-phosphates and concomitant hydrolysis of polyphosphoinositol lipids. In [3H]arachidonate-prelabelled hVSMC endothelin promoted production of diacylglycerol, the early kinetics of which parallelled polyphosphoinositol lipid hydrolysis. Such phospholipase C activation by endothelin was sustained in hVSMC with accumulation of inositol polyphosphates being markedly protracted and the decay of diacylglycerol slow. Endothelin promoted extracellular release of [3H]arachidonate-labelled material from hVSMC which derived via deacylation of both phosphatidylinositol and phosphatidylcholine. This process was inhibited by phospholipase A2 and lipoxygenase inhibitors, but insensitive to phospholipase C and cyclooxygenase inhibitors. Endothelin-induced activation of phospholipase C and phospholipase A2 signal transduction pathways (EC50 approximately 5-8 nM for both) in hVSMC apparently proceed in an independent parallel manner rather than a sequential one.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159883     DOI: 10.1111/j.1432-1033.1990.tb15504.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Pulmonary artery smooth muscle cell endothelin-1 expression modulates the pulmonary vascular response to chronic hypoxia.

Authors:  Francis Y Kim; Elizabeth A Barnes; Lihua Ying; Chihhsin Chen; Lori Lee; Cristina M Alvira; David N Cornfield
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-14       Impact factor: 5.464

2.  What is the role of bosentan in healing of femur fractures in a rat model?

Authors:  Ali Aydin; Zekai Halici; Erol Akpinar; A Murat Aksakal; Murat Saritemur; Muhammed Yayla; C Semih Kunak; Elif Cadirci; H Tarik Atmaca; S Sena Karcioglu
Journal:  J Bone Miner Metab       Date:  2014-10-09       Impact factor: 2.626

Review 3.  Endothelin and heart failure.

Authors:  P Nambi; M Clozel; G Feuerstein
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

4.  Endothelin rapidly stimulates mitogen-activated protein kinase activity in rat mesangial cells.

Authors:  Y Wang; M S Simonson; J Pouysségur; M J Dunn
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

5.  Conceptual approaches for treatment of phosgene inhalation-induced lung injury.

Authors:  Wesley W Holmes; Brian M Keyser; Danielle C Paradiso; Radharaman Ray; Devon K Andres; Betty J Benton; Cristin C Rothwell; Heidi M Hoard-Fruchey; James F Dillman; Alfred M Sciuto; Dana R Anderson
Journal:  Toxicol Lett       Date:  2015-11-10       Impact factor: 4.372

6.  A comparative study of endothelin- and platelet-activating-factor-mediated signal transduction and prostaglandin synthesis in rat Kupffer cells.

Authors:  C R Gandhi; K Stephenson; M S Olson
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

7.  Endothelin-1 downregulates sperm phagocytosis by neutrophils in vitro: A physiological implication in bovine oviduct immunity.

Authors:  Mohamed Ali Marey; Mohamed Samy Yousef; Jinghui Liu; Kazuhiro Morita; Motoki Sasaki; Hiroyuki Hayakawa; Takashi Shimizu; Ibrahim I Elshahawy; Akio Miyamoto
Journal:  J Reprod Dev       Date:  2016-01-18       Impact factor: 2.214

8.  Bosentan, a drug used in the treatment of pulmonary hypertension, can prevent development of osteoporosis.

Authors:  Duygu Köse; Ahmet Köse; Zekai Halıcı; Elif Çadırcı; Taha Tavacı; Muhammed Ali Gürbüz; Adem Maman
Journal:  Iran J Basic Med Sci       Date:  2021-07       Impact factor: 2.699

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.